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Abstract
A novel multi-organ disease that is fatal in early childhood was identified in three patients from two non-consanguineous 
families. These children were born asymptomatic but at the age of 2 months they manifested progressive multi-organ symp-
toms resembling no previously known disease. The main clinical features included progressive cerebropulmonary symptoms, 
malabsorption, progressive growth failure, recurrent infections, chronic haemolytic anaemia and transient liver dysfunction. 
In the affected children, neuropathology revealed increased angiomatosis-like leptomeningeal, cortical and superficial white 
matter vascularisation and congestion, vacuolar degeneration and myelin loss in white matter, as well as neuronal degen-
eration. Interstitial fibrosis and previously undescribed granuloma-like lesions were observed in the lungs. Hepatomegaly, 
steatosis and collagen accumulation were detected in the liver. A whole-exome sequencing of the two unrelated families 
with the affected children revealed the transmission of two heterozygous variants in the NHL repeat-containing protein 2 
(NHLRC2); an amino acid substitution p.Asp148Tyr and a frameshift 2-bp deletion p.Arg201GlyfsTer6. NHLRC2 is highly 
conserved and expressed in multiple organs and its function is unknown. It contains a thioredoxin-like domain; however, 
an insulin turbidity assay on human recombinant NHLRC2 showed no thioredoxin activity. In patient-derived fibroblasts, 
NHLRC2 levels were low, and only p.Asp148Tyr was expressed. Therefore, the allele with the frameshift deletion is likely 
non-functional. Development of the Nhlrc2 null mouse strain stalled before the morula stage. Morpholino knockdown of 
nhlrc2 in zebrafish embryos affected the integrity of cells in the midbrain region. This is the first description of a fatal, 
early-onset disease; we have named it FINCA disease based on the combination of pathological features that include fibrosis, 
neurodegeneration, and cerebral angiomatosis.
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Introduction
Recent developments in network-based approaches have 
led to the discovery of disease-causing genes, the unex-
pected links between apparently unrelated diseases, diag-
nostic biomarkers and therapeutic targets for cancer, dia-
betes and several neurodegenerative diseases including 
Alzheimer’s, Parkinson’s, and Huntington’s diseases [2, 
21]. Rare, inherited mutations causing familial neurode-
generative diseases provide the molecular basis for the 
cellular pathways underlying the pathogenesis of diseases, 
including the accumulation of aberrant or misfolded pro-
teins, protofibril formation, ubiquitin–proteasome system 
dysfunction, excitotoxic insult, oxidative and nitrosa-
tive stress, mitochondrial injury, synaptic failure, altered 
metal homeostasis and failure of axonal and dendritic 
transport [3]. Chronic, progressive pulmonary disorders 
include interstitial fibrosis, granulomatous changes and 
diffuse alveolar damage caused by various pathogenetic 
and genetic mechanisms [24]. However, the current under-
standing of the molecular basis of degenerative disease-
related mechanisms, such as tissue fibrosis, neurodegen-
eration and angiogenesis, remains incomplete.
The research field focusing on molecular genetic aetiolo-
gies and cellular mechanisms of inherited human diseases 
has undergone a major revolution in the last decade because 
of modern research technology that includes whole-exome 
sequencing (WES) and bioinformatic analyses, which pro-
vide better means to identify novel proteins, cellular path-
ways and disease mechanisms. Herein, we characterise a 
novel, early-onset and progressive multi-organ disease 
presenting mainly as severe cerebropulmonary manifes-
tations that eventually led to death in infancy. We present 
the clinical, radiological and histological characterisations 
of this multi-organ disease, which we named FINCA dis-
ease based on the unique histopathological findings of the 
patients (fibrosis, neurodegeneration, and cerebral angioma-
tosis). According to our WES analysis, all three affected 
children with FINCA disease harboured an identical combi-
nation of variants in the NHL repeat containing 2 (NHLRC2) 
gene encoding NHLRC2, a protein with a thioredoxin-like 
domain. However, its function is currently uncharacterised, 
enabling no direct biochemical assay to address the patho-
logical role of the variants identified. To acquire more infor-
mation about the function of NHLRC2 in vivo, we studied 
the effects of knocking out or down the expression of Nhlrc2 
in mice and zebrafish models, respectively. Finally, our data 
suggest that NHLRC2 is an important factor in the mainte-
nance of multi-organ homeostasis, indicating a wider role 
for NHLRC2 in the pathogenesis of degenerative human 
diseases.
Materials and methods
Study subjects
As part of the diagnostic protocol, skin and skeletal mus-
cle biopsy samples were collected from three patients with 
severe, early-onset undefined progressive cerebropulmo-
nary and multi-organ disease. The patients were examined 
at the Department of Paediatrics of Oulu University Hospital 
from 2001 to 2003 (Patients 1 and 2 from Family A) and 
from 2010 to 2011 (Patient 3 from Family B). Investigations 
included clinical assessments and radiological, histological, 
biochemical and molecular genetic analyses. Based on the 
severe, multi-organ phenotype, a mitochondrial disease was 
suspected, and muscle biopsies were performed; however, 
there were no specific abnormal findings. Mitochondrial res-
piratory chain enzyme activities were normal, there were 
no deletions in muscle mitochondrial DNA. The Sanger 
sequencing revealed no pathogenic variants in the coding 
region of mtDNA, or exons and exon–intron boundaries 
of the genes encoding mitochondrial twinkle helicase and 
polymerase gamma. Furthermore, CLN1, NKX2-1, SFTPB, 
ABCA-3 and SFTPC genes were sequenced to exclude infan-
tile neuronal ceroid lipofuscinosis, brain–lung–thyroid syn-
drome and gene defects related to surfactant proteins; no 
pathogenic variants were found in these genes. The disease 
course was progressive, leading to the early deaths of all 
the patients.
Histopathological studies of tissue samples (see 
Electronic Supplementary Material)
Tissue biopsies (lung and skeletal muscle biopsies) and 
autopsy samples were obtained from all three affected 
patients. The tissue was fixed in buffered 4% formaldehyde, 
routinely processed into paraffin blocks and cut into 5.0-μm 
sections. Hematoxylin and eosin and luxol fast blue stainings 
were performed as previously described [1].
Transmission electron microscopy on patient tissue 
samples and zebrafish nhlrc2 morphants
Autopsy samples from the lungs and liver from Patient 2 
and whole zebrafish embryos at 2 days post-fertilisation 
(dpf) injected with random sequence (5.1 ng) or splice 
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site-blocking morpholino (5.0 ng) were fixed in 1% glutar-
aldehyde and 4% formaldehyde in 0.1 M phosphate buffer 
and were then post-fixed with 1% osmium tetroxide (Elec-
tron Microscopy Sciences, Hatfield, PA, USA), dehydrated 
in acetone and embedded in Epon LX112 (#21210; Ladd 
Research Industries Inc., Williston, VT, USA). Thin sections 
were cut with a Leica Ultracut UCT microtome (FC6; Leica, 
Wetzlar, Germany), stained with uranyl acetate (Structure 
Probe Inc., West Chester, PA, USA) and lead citrate (Lau-
rylab, Brindas, France) and examined with a Tecnai Spirit 
transmission electron microscope (FEI Company, Eind-
hoven, Netherlands). Images were captured with a Quemesa 
CCD camera (Olympus Soft Imaging Solutions, Münster, 
Germany). Specimens for electron microscopy were pro-
cessed and analysed in the EM core facility at Biocenter 
Oulu (Oulu, Finland).
Molecular genetic analyses and genealogy (see 
Electronic Supplementary Material)
Whole-exome sequencing (WES) [25] and bioinformatics 
analysis [31] were performed on samples from both fami-
lies. Using Sanger sequencing, we confirmed variants and 
segregation within the families. To investigate the heredity 
of the mutations, we traced the ancestors of the patients in 
the Finnish Population Registries and National Archives of 
Finland [29].
Screening of NHLRC2 variants in population cohorts
To determine whether the two NHLRC2 variants were pre-
sent in the general Finnish population, we used two strate-
gies. First, we examined these variants in a Finnish popula-
tion of infants born at term (gestational age ≥ 37 weeks, total 
n = 306) sampled prospectively at Oulu University Hospital 
from 2004 to 2007 (n = 199) [10] and in 2014 (n = 107). 
The individuals born in this hospital mostly originate from 
northern Finland; therefore, these infants represent a valid 
population control. Next, we searched the Sequencing Ini-
tiative Suomi (SISu) [7] and ExAC data [13] (http://exac.
broad insti tute.org/;01,2017) for the variants. The SISu data 
currently covers exonic variants of 10,490 individuals of 
Finnish origin.
NHLRC2 expression and function (see Electronic 
Supplementary Material)
After reverse-transcription PCR (RT-PCR), we used Sanger 
sequencing to investigate the expression of the mutant 
alleles. Protein expression in the whole-cell extracts of 
fibroblasts from all three patients and healthy control sub-
jects, together with the homogenates of control autopsy 
samples from several types of human tissues, were analysed 
by immunoblotting. Two constructs containing either full-
length human NHLRC2 or the thioredoxin-like domain alone 
were expressed in the E. coli strain BL21 (DE3). An insulin 
turbidity assay to test thioredoxin activity was performed, 
as previously described [9].
Nhlrc2 knockout mice (see Electronic 
Supplementary Material)
Heterozygous C57BL/6N-Atm1Brd  Nhlrc2tm1a(KOMP)Wtsi/Wtsi 
mice were obtained from the Infrafrontier-EMMA reposi-
tory (strain number EM: 10219). These mice carry a mutated 
allele where the function of the Nhlrc2 gene is inactivated by 
the insertion of a targeting cassette that contains the expres-
sion reporter beta galactosidase gene [26]. Heterozygous 
mice were cross-bred, pups were genotyped or pregnant 
females dissected and embryos analysed. The expression of 
Nhlrc2 in embryos was studied by staining for the expression 
of the lacZ reporter. On embryonic day 2.5 (E2.5), morulae 
were flushed from the uterus in accordance with a previously 
described protocol [18]. Embryos that were grown overnight 
in a microculture drop were transferred onto a gelatinised 
24-well plate, each into its own well with 300 µl of embry-
onic stem cell medium, and left to grow for 10–12 days, after 
which DNA was extracted, as described [22].
Generation of zebrafish morphants (see Electronic 
Supplementary Material)
Two morpholinos against zebrafish nhlrc2 (ENS-
DARG00000089581) were designed; the first morpholino 
was against the ATG-site to prevent translation and the sec-
ond against the exon–intron boundary in the 3′ end of exon 4 
(ENSDARE00000919598) to prevent splicing, which would 
both lead to a frameshift and premature termination of trans-
lation. The effect of the splice site-blocking morpholino for 
nhlrc2 levels was quantified using PCR. The knockdown 
efficiency was determined from an agarose gel using ImageJ 
v1.49 by calculating the ratio of the wild-type (WT, the 
unmodified band) to the sum of all bands in a single lane 
(WT and two morpholino-modified bands corresponding to 
exon exclusion and intron inclusion caused by splice site 
blocking).
Quantification of the affected cells in the midbrain 
region of zebrafish morphants from transmission 
electron micrographs
From five zebrafish injected with random sequence con-
trol morpholino (5.1 ng) and five zebrafish injected with 
nhlrc2 splice site-blocking morpholino (5.0 ng), five ran-
dom electron micrographs were taken from sagittal thin sec-
tions of the midbrain area. All the cells with visible nuclei 
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and entirely within the imaged area were counted and ana-
lysed for their integrity using iTEM software (Olympus Soft-
ware Imaging Solutions GMBH, Münster, Germany). Cells 
with excess vacuolisation or disintegration were classified 
as affected.
Statistics
Differences were considered statistically significant (*) if the 
p value was 0.01–0.05, very significant (**) if the p value 
was 0.001–0.01, and highly significant (***) if the p value 
was < 0.001. A paired two-tailed Student’s t test was used 
to analyse the statistical significance. Zebrafish dechoriona-
tion timing differences were calculated with the log rank 
Mantel–Cox method, and values below 0.05 were considered 
significant.
Results
Clinical findings
Family A Two brothers were born after normal consecutive 
singleton pregnancies to healthy parents in this non-consan-
guineous Finnish family. Both siblings presented at 2 months 
of age with feeding problems, muscular hypotonia, shoul-
der hypertonia and irritability. During the following months, 
both had delayed development, recurrent infections, growth 
failure, respiratory problems and malabsorption. They sub-
sequently developed dystonic tetraplegia, poor visual con-
tact, progressive respiratory difficulties, transient liver dys-
function, and chronic haemolytic anaemia. The elder brother 
additionally presented with epileptic seizures and kidney 
dysfunction related to metabolic crisis at 9 months. The 
disease course was progressive and, despite intensive care, 
both patients died (at 1 year 9 months and 1 year 1 month, 
respectively) of progressive respiratory failure.
Family B In this non-consanguineous Finnish family, 
the affected son was the first infant born to healthy parents. 
The mother had gestational hepatosis and toxaemia. At 
2 months, the infant presented with irritability, floppiness, 
haemolytic anaemia, feeding problems, frequent diarrhoea 
and poor weight gain. At 4 months, he was hospitalised 
because of a suspected seizure, poor general condition and 
respiratory problems. During the following months, he had 
delayed development, dystonia, failure to thrive, strabis-
mus, recurrent infections, and respiratory difficulties. The 
disease course was progressive, and despite intensive care, 
the patient passed away at 1 year 2 months due to respira-
tory failure.
All three patients appeared healthy at birth, but mani-
fested at 2 months with unique multi-organ symptoms with a 
progressive disease course that resembled no known disease 
phenotype. Table 1 summarises the major clinical find-
ings, including progressive cerebropulmonary symptoms, 
transient liver dysfunction, progressive growth failure and 
chronic haemolytic anaemia. Radiological investigations 
revealed over-inflated lungs with perihilar interstitial opaci-
ties, diffuse infiltrations and atelectasis (Online Resource 
Fig. 7) and thin corpus callosum (Online Resource Fig. 8). 
Additional findings included increased echogenicity of the 
kidneys (Patient 1) and hepatomegaly during metabolic cri-
sis (Patients 1 and 2), enlarged thymus (Patient 2) (Online 
Resource Fig. 9), dilated lateral ventricles, frontal sulci 
resembling cerebral atrophy (Patients 2 and 3) and increased 
signal intensity of the globus pallidum (Patient 3) (Online 
Resource Fig. 8). Visual evoked potentials (VEPs) revealed 
increased latencies and giant responses, indicating dysfunc-
tion of the visual tract (Patient 1). Electroencephalographs 
(EEGs) showed slow background activity and frontal bilat-
eral rhythmic high-amplitude sharp delta transients, indi-
cating metabolic encephalopathy (Patient 1). The EEG of 
Patient 3 was normal at 5 months, but at 11 months it was 
monotonic during sleep and consisted of 4-Hz delta waves 
without normal sleep spindles and vertex waves. Detailed 
descriptions of the clinical manifestations are presented in 
the Electronic Supplementary Material.
Histopathological findings in the brain
Post mortem neuropathological examinations were per-
formed for all three patients. The findings in Patient 1 
included brain atrophy (942 g, reference 1050 g); thin corpus 
callosum; small hippocampal regions and increased angio-
matosis-like leptomeningeal, cortical and superficial white 
matter venous and capillary vascularisation and congestion 
(Fig. 1a). Superficial vascular changes were observed mac-
roscopically. Widespread cerebral cortical oedema, focal 
neuronal loss and gliosis were observed (Fig. 1b, c). Sym-
metrical vacuolar degeneration and myelin loss of the fibres 
at the level of the crus cerebri in the midbrain were detected, 
as well as vacuolar degeneration of the white matter of the 
cerebellum, cerebellar oedema, focal Purkinje cell deple-
tion and gliosis (Fig. 1d). Neuronal depletion of the anterior 
horns of the spinal cord was also found.
Patient 2 also had brain atrophy (764 g, reference 900 g), 
a thin corpus callosum and prominent congested leptome-
ningeal and superficial brain parenchymal vasculature. Fur-
thermore, the following neurodegenerative findings were 
detected: vacuolar degeneration and myelin loss of the 
corpus callosum and central white matter; vacuolar degen-
eration of the optic tract and the internal capsule; neuronal 
depletion of the corpora mammillaria, hypothalamic area 
and amygdaloid nucleus, as well as subthalamic and tha-
lamic nuclei; vacuolar degeneration and myelin loss of the 
fibres of the crus cerebri and superior cerebellar peduncle 
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and reticular formation in the midbrain, tegmentum and 
medial lemniscus in the pons (Fig. 1e–h). Other findings 
included mild vacuolar degeneration, myelin loss of the 
fibres of the pyramids and reticular formation in the medulla 
and in the white matter of the cerebellum. In addition, there 
was patchy neuronal loss in the anterior horns of the spinal 
cord.
Examinations of samples from Patient 3 revealed brain 
atrophy (742 g, reference 860 g), but a mostly normal cor-
pus callosum, cerebral cortex and hippocampus. However, 
vascular congestion and angiectasia were detected. The tem-
poral white matter exhibited vacuolar degeneration. Further-
more, the following findings were detected: vacuolar degen-
eration and neuronal depletion in the hypothalamic and 
amygdaloid nuclei and the putamen; vacuolar degeneration 
and myelin loss in the spinothalamic tract, medial lemniscus, 
superior cerebellar peduncle and reticular formation; degen-
eration of the anterior pontine nuclei; and minimal vacuolar 
degeneration in the white matter and dentate nucleus of the 
cerebellum.
Histopathological findings in the lungs
The lung biopsy samples from Patients 2 and 3 revealed no 
normal lung tissue; the lung tissue had been replaced by 
interstitial fibrosis resembling what is normally associated 
with non-specific interstitial pneumonia (NSIP) (Fig. 2a, 
b). The alveolar epithelial cells appeared hyperplastic, and 
there were focal loose fibrotic areas positive after Alcian 
blue/periodic acid–Schiff (AB-PAS) staining. No hyaline 
membranes or diffuse alveolar damage (DAD) were visible.
Autopsy samples of the lungs were available from all 
three patients, and all the samples showed varying amounts 
of interstitial changes and fibrosis (Fig. 2c–h). Interstitial 
fibrosis in the lungs of Patient 1 was milder than in the lungs 
of his younger brother (Patient 2) (Fig. 2c). The lungs of 
Table 1  Clinical findings for the three patients with FINCA disease
Findings Patient 1 Patient 2 Patient 3
Duration of gestation 38 weeks 38 + 6 weeks 36 + 1 weeks
Birth weight/length/head circumference 3690 g/49 cm/35 cm 3280 g/51 cm/34.5 cm 2910 g/46 cm/33 cm
Apgar score 10/10 9/9 10/10
Age at disease onset 2 months 2 months Birth to 2 months
Neurological symptoms
Irritability + + +
Axial hypotonia + + +
Dystonia + + +
Developmental delay + + +
Feeding problems + + +
Poor visual contact + + +
Seizures + − +
Respiratory symptoms
Recurrent respiratory infections + + +
Progressive respiratory insufficiency + + +
Ophthalmological findings
Decreased vision + + +
Strabismus + + +
Gastrointestinal and cardiac symptoms and signs
Diarrhoea + + +
Hepatomegaly + + +
Feeding problems, poor weight gain, growth failure + + +
Cardiomegaly + − −
Haematological findings
Chronic haemolytic anaemia + + +
Metabolic crises
Transient liver dysfunction during viral infection + + −
Transient kidney dysfunction during viral infection + − −
Progressive course of disease + + +
Age at death 1 year 9 months 1 year 1 month 1 year 2 months
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Patient 2 revealed advanced interstitial fibrosis as a promi-
nent feature, which was consistent with the findings in the 
lung biopsy samples; however, the degree of fibrosis in the 
autopsied lungs was more severe. In the lungs of Patient 
3, the fibrosis was mainly moderate or mild. The general 
histological appearance of the autopsied lungs resembled 
that of NSIP. Intra-alveolar hyaline, hyaline membranes and 
squamous epithelial metaplasia reflecting DAD were inter-
mittently observed in the lungs of Patients 1 and 3 but not in 
Patient 2 (Fig. 2g). Novel histopathological structures that 
Fig. 1  Histopathological findings in brain autopsy samples from 
patients with NHLRC2 variants. a Autopsy findings from Patient 1 
revealed increased angiomatosis-like leptomeningeal vascularisation. 
b Degeneration and depletion of the pyramidal cells of the hippocam-
pus. c Higher magnification of the Ammon’s horn showing gradual 
depletion of pyramidal neurons. d Depletion of Purkinje cells of the 
cerebellum (between arrowheads). e–h Patient 2 had vacuolar degen-
eration and myelin depletion in the pons. Haematoxylin and eosin 
stain (a–f) and luxol fast blue stain (g, h). The images were taken 
with an Aperio AT2 digital pathology slide scanner (Leica Biosys-
tems, Wetzlar, Germany). Scale bars: 200 µm
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we have termed granuloma-like lesions were observed in all 
cases, but in varying numbers; multiple lesions in five lung 
tissue sections in Patient 1, hundreds of lesions in five lung 
tissue sections in Patient 2 and fewer than 10 lesions in eight 
lung tissue sections of Patient 3 (Fig. 2c, e, h). Hyaline-
resembling fibrotic areas were observed around the arter-
ies in all cases, but the walls of the vessels were otherwise 
normal (Fig. 2d, e). Some airways were dilated, but no true 
honeycombing was found.
Most of the granuloma-like lesions were surrounded by 
hyaline-resembling extracellular material that contained 
large spindle-shaped cells. These large spindle-shaped 
cells were positive for alpha-smooth muscle actin (α-SMA) 
(myofibroblast marker) and negative for cytokeratin (epi-
thelial cell marker), phosphoglucomutase 1 (PGM1) (mac-
rophage marker), smooth muscle myosin heavy chain 
(SMMHC) (smooth muscle cell marker) and caldesmon 
(smooth muscle cell marker) (Fig. 2f). The immunohisto-
chemical phenotype indicated that the cells in the granu-
loma-like lesions were myofibroblasts.
Histopathological findings in the other organs
All three patients had hepatomegaly (435–485 g, reference 
weight 330–370 g). An autopsy liver sample from Patient 
1 showed widespread microvesicular steatosis and foci of 
hepatocellular necrosis. Patient 1 also had cardiomegaly 
(90 g, reference weight 56 g) with slightly increased con-
nective tissue. Autopsy revealed mild muscular atrophy in 
Patients 1 and 2; previous muscle biopsy samples from these 
patients revealed no histopathological changes. Further-
more, upon histological examination, the autopsy revealed 
atrophic thymus and adrenal glands without any specific 
abnormalities.
Electron microscopic findings in the lungs and liver
We analysed lung and liver autopsy samples from Patient 
2 using a transmission EM (TEM). In the lungs, the most 
abundant cell types were myofibroblasts and smooth muscle 
and alveolar epithelial cells (Fig. 3a–c). Alveolar epithe-
lial cells were mostly type II cells with intracellular lamel-
lar bodies; only a few type I alveolar cells were detected 
(Fig. 3a, b). In the liver tissue samples, we observed steatosis 
(Fig. 3d) and collagen accumulation both inside- and outside 
of the hepatocytes, and a basement membrane was evident 
in the space of Disse (Fig. 3e, f).
Variants of NHLRC2 in the two families
WES revealed compound heterozygous variants in 
NHLRC2, in all three affected children (Fig.  4a). 
The NHLRC2 gene is located in chromosome 10: 
113,854,661–113,917,194 and encodes for the poorly 
characterised NHLRC2 containing an N-terminal thiore-
doxin-like domain together with six NHL amino acid 
sequence repeats (named after three original genes NCL-
1, HT2A and LIN-41) (Fig. 4b) [23]. Previously, muta-
tions in NHLRC2 have not been associated with any 
other human disease. The FINCA patients carried the 
heterozygous variant NM_198514:c.442G>T, which led 
to amino acid substitution p.Asp148Tyr in exon 3 within 
the highly conserved thioredoxin-like domain (Fig. 4b, d, 
Online resource Fig. 10). However, in the classical insu-
lin-reduction activity assay for thioredoxins, neither full-
length NHLRC2 nor the isolated thioredoxin-like domain 
produced in E. coli showed significant thioredoxin activity 
(Fig. 4c).
In addition, all three patients had a heterozygous 
frameshift 2-bp deletion NM_198514:c.601_602delAG, 
which caused p.Arg201GlyfsTer6 in exon 3 (Fig. 4a, b, 
Online Resource Fig. 10). Both the variants were segre-
gated from their healthy parents. Genealogies of the patients, 
traced back 7–9 generations to the 1750s, revealed that the 
two families did not have common ancestors. We were una-
ble to confirm the consanguinity of these two core families; 
their ancestors were born in northern Finland at least 150 
miles apart.
Allele frequency of NHLRC2 variants 
among populations
We did not detect p.Asp148Tyr or p.Arg201GlyfsTer6 vari-
ants in the northern Finnish cohort of infants (n = 306). 
In the Finnish population represented by Sequencing Ini-
tiative Suomi (SISu) data (n  =  10,488), p.Asp148Tyr 
(rs201701259) was rare, with a frequency of 0.003. In SISu, 
a frequency of 0.0001 was reported for p.Arg201GlyfsTer6 
(rs757267294); however, the variant had not passed through 
quality control. In the Exome Aggregation Consortium 
(ExAc) data, the p.Asp148Tyr variant was present in non-
Finnish European (n = 33,351), South Asian (n = 8252), and 
African (n = 5202) populations with frequencies of 0.0003, 
0.0002 and 0.0001, respectively. The p.Arg201GlyfsTer6 
variant had a frequency of 0.0001 in non-Finnish Europeans 
(n = 33,239) and was absent from other populations. The 
two variants were not detected as homozygous occurrences 
in any of the populations.
According to the SISu data, at least one of the two 
NHLRC2 variants, p.Asp148Tyr (rs201701259), was 
enriched in the Finnish population (n = 10,488; natural 
logarithm of odds ratio 1.97), indicating that occurrence of 
the two variants in a compound heterozygous state in the 
two core families may be, at least partly, explained by their 
enrichment in the Finnish population.
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Expression of human NHLRC2
We investigated mRNA expression of var iants 
NM_198514:c. 442G>T and c.601_602delAG in the 
patients’ fibroblasts. NHLRC2 mRNA expressed only the 
c.442G>T missense variant and not c.601_602delAG, 
confirming the origin of the variants from separate alleles 
and the degradation of mRNA with the frameshift 2-bp 
deletion (Online Resource Fig. 10). The relative quan-
tity of NHLRC2 expression was studied by qPCR and 
showed approximately a twofold decrease in patient-
derived, immortalised fibroblasts compared to the controls 
(Fig. 4e).
The protein expression of NHLRC2 with the 
p.Asp148Tyr variant was investigated in the immortal-
ised fibroblasts derived from patients and healthy con-
trols. Immunoblotting revealed approximately a tenfold 
decrease in the levels of NHLRC2 in whole-cell extracts 
from patients compared to control fibroblasts (Fig. 4f, g), 
further indicating the non-neutral role of the NHLRC2 
variants.
Immunoblotting was also performed to investigate the 
expression of NHLRC2 in tissue homogenates from con-
trol autopsy samples (kidney, heart, muscle, liver, lung and 
brain tissue). NHLRC2 was detected in all human tissues 
included in the study (Online Resource Fig. 11). According 
to three public RNA expression databases (mouse) Brain 
RNA-Seq (https ://web.stanf ord.edu/group /barre s_lab/brain 
_rnase q.html) [32], Human Brain Transcriptome (http://
hbatl as.org/) and the Atlas of the Developing Human Brain 
(http://www.brain span.org) [12], the expression of mouse 
Nhlrc2 is highest in astrocytes, oligodendrocyte progenitor 
cells, newly formed oligodendrocytes and endothelial cells. 
Mouse Nhlrc2 is also expressed in neurons, myelinating 
oligodendrocytes and microglia. According to the Atlas of 
the Developing Human Brain (http://www.brain span.org) 
[16], expression of human NHLRC2 was highest in foetal 
brains during early pregnancy. The average expression levels 
of human NHLRC2 are similar among the cerebellar cor-
tex, mediodorsal nucleus of the thalamus, striatum, amyg-
dala, hippocampus and 11 areas of the neocortex (Online 
Resource Fig. 12).
Nhlrc2tm1a knockout mice
Nhlrc2 knockout (KO) mice (21 litters, n = 154) were gen-
otyped from heterozygous breeding pairs (Table 2). The 
ratio of born mice between WT and heterozygous mice was 
1:2.125, which is in line with Mendelian segregation. The 
heterozygous mice, both female and male, were vital and 
bred well, indicating normal function of  Nhlrc2tm1a KO 
gametes. We also genotyped 53 embryos from six heterozy-
gous breeding pairs on E10.5 and isolated and genotyped 
45 morulae (E2.5) from six heterozygous breeding pairs 
(Online Resource Fig. 13). We did not detect any homozy-
gous Nhlrc2 KO mice, embryos or morulae, indicating that 
the lethality of  Nhlrc2tm1a KO homozygotes occurs between 
the fertilisation and morula (E2.5) stage. Nhlrc2 expression 
analysis with LacZ-reporter mice indicated widespread 
expression throughout the body while WT littermates 
remained negative (Fig. 5). RNA in situ data of the Eur-
express atlas (www.eurex press .org/ee/) showed strongest 
Nhlrc2 expression in the brain, the central nervous system, 
the alimentary system and in the cardiovascular system of 
mouse embryos (E14.5) [4].
Zebrafish knockdown and dechorionation
We then decided to study the role of nhlrc2 in early embryo-
genesis using zebrafish, which is a convenient model organ-
ism for developmental studies because of the transparency 
of the embryos. The morphogenesis of the primary organ 
systems of a zebrafish is complete in 48 h and the larvae 
display food seeking and avoidance behaviour 72 h after 
conception [11]. First, we assessed the efficacy of nhlrc2 
splice site-blocking morpholino with PCR. As predicted, 
morphants had altered mRNA splicing compared to the 
untreated controls. The effect gradually faded toward 4 dpf 
(Online Resource Fig. 14). Besides minor swelling in the 
abdomen, nhlrc2 morphants developed normally (Online 
Resource Fig.  14) without any apparent developmental 
defects. Both splice site-blocking morpholino (3.6 ng) and 
translation-blocking morpholino (2.3 ng) were used, with 
both co-injected with an equal amount of p53 morpholino 
[20]. A slight delay was observed in the timing of the decho-
rionation (Online Resource Fig. 15a), but a similar effect 
was also observed in the random controls (Online Resource 
Fig. 15b), suggesting both were non-specific effects.
Because there were no apparent changes in the gross mor-
phology of developing nhlrc2 morphants, we next investi-
gated the central nervous system in more detail using TEM. 
Because we were not able to ascertain the effect of the trans-
lation-blocking morpholinos without a validated antibody, 
we chose to use the splice site-blocking morpholinos for 
the TEM analysis. In this experiment, we achieved approxi-
mately 95.2% knock-down efficiency at the time point of 
Fig. 2  Histological findings in lung samples from patients with 
NHLRC2 variants. a, b Interstitial fibrosis was present in the lung 
biopsy samples. c–f, h Granuloma-like lesions (arrows) within 
regions with variable amounts of necrosis (stars) were present in 
the autopsy samples from each patient. d Perivascular fibrosis was 
visible around the artery (arrowhead). f Spindle-shaped cells in a 
granuloma-like lesion were positive for alpha-smooth muscle actin 
(short arrows). g Hyaline membranes (short arrows) were present in 
the alveoli. Lung samples collected by lung biopsy (a, b) and during 
autopsy (c–h). Samples from Patient 1 (c), Patient 2 (a, d–f) and from 
Patient 3 (b, g, h). Haematoxylin and eosin stain (a–e, g, h). Scale 
bars: 80 µm
◂
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2 dpf by using the splice site-blocking nhlrc2 morpholino 
(5.0 ng) (Online Resource Fig. 16). Using TEM, the quan-
titative analysis of the midbrain region from the 2 dpf mor-
phants showed statistically significant increments in the 
number of affected cells in nhlrc2 knock-downs compared 
to the controls injected with a random sequence morpholino 
(Fig. 6). The data indicate that nhlrc2 has a key role in main-
taining the cellular integrity of the central nervous system in 
developing zebrafish embryos.
Discussion
Based on clinical and molecular genetic data we have iden-
tified a novel cerebropulmonary and multi-organ disease, 
which we have named FINCA. This disease is characterised 
by a unique combination of tissue fibrosis, neurodegenera-
tion and cerebral angiomatosis. Using WES we identified 
identical compound heterozygous NHLRC2 variants in three 
affected children from two unrelated families. In addition, 
we used a KO mouse model and zebrafish morphants to 
investigate the consequences of absent or decreased Nhlrc2 
expression; finally, we performed biochemical studies on 
human recombinant NHLRC2.
NHLRC2 is conserved in eukaryotes, having 84% 
sequence identity between human and mouse orthologues. 
The function of NHLRC2 is currently unknown. There are 
two NHLRC2 transcript variants in humans, both contain-
ing six NHL repeats that may form part of a TolB-like 
six-bladed beta-propeller. Six-bladed beta-propellers occur 
in a wide range of proteins, including 165 human proteins 
listed in InterPro [17]. They are often involved in pro-
tein–protein interactions. The longer isoform of NHLRC2 
also has an N-terminal thioredoxin-like domain with an 
unusual motif (CCINC), where the active site of thiore-
doxin (WCGPC for human thioredoxins 1 and 2) is usu-
ally located. Interestingly, the missense variant identified 
from the patients in this study located in the thioredoxin-
like domain and led, together with the frameshift vari-
ant, to significantly reduced expression of NHLRC2 at the 
mRNA and protein level in patient-derived fibroblasts. A 
classical insulin-reduction activity assay for thioredoxins 
revealed that neither full-length NHLRC2 nor the isolated 
thioredoxin-like domain showed significant thioredoxin 
activity. This may be because of the substrate specificity 
of NHLRC2, which could be mediated by protein–protein 
interactions involving the six-bladed beta-propeller. Thus, 
insulin may be excluded from the active site; however, 
the thioredoxin fold motif is versatile, with both redox 
[15] and non-redox functions. An example of a non-redox 
function occurs in SasA, a circadian clock-associated his-
tidine kinase [28]. This versatility plus the unusual motif 
in place of the active site indicates that the N-terminal 
domain has a thioredoxin fold, but no thioredoxin activity. 
Fig. 3  Electron microscopy analysis of lung (a–c) and liver (d–f) 
autopsy samples. a Lung alveoli contained type II pneumocytes (P) 
and the alveolar space was very limited (L, the lumen of the alveo-
lus). b In addition to type II pneumocytes (P), myofibroblasts (M) 
were present with diverging ‘limb-like’ projections. The square is 
delineating the area magnified in c Myofibroblasts with ultrastructural 
features such as abundant endoplasmic reticulum (E) and adherens 
junctions (A) had produced fibrotic extracellular collagen bundles 
(C). d The liver had many large fat (F) vacuoles in the hepatocytes. 
e Thin and fragmentary basement membrane (B) was detected in the 
space of Disse adjacent to the endothelial cells surrounding the sinu-
soidal lumen (L). f The accumulation of fat vacuoles (F) and collagen 
bundles (C) in hepatocytes. Sinusoidal lumen (L). Scale bars: 10 µm 
(a, d), 5 µm (b), 2 µm (c, e, f)
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Conservation of the active-site cysteines indicates that the 
protein either has or regulates a redox-related function.
Based on large population cohort datasets, the rare vari-
ants identified in our patients are not restricted to the Finnish 
population; they are also present as simple heterozygotes in 
other populations. Our genotyping analysis of Nhlrc2 KO 
mice, foetuses and morulae revealed that homozygosity was 
lethal, whereas heterozygous mice were viable and non-
symptomatic. Interestingly, the nhlrc2 morphant zebrafish 
embryos had a significant number of affected cells in the 
midbrain, indicating that nhlrc2 has an important role in 
the maintenance of cell survival in the developing brain. In 
Fig. 4  Variants p.Asp148Tyr and p.Arg201GlyfsTer6 in NHLRC2 
in patients with FINCA disease from two non-consanguineous 
families. a Pedigrees and the segregation of heterozygous vari-
ants p.Asp148Tyr and p.Arg201GlyfsTer6 in Families A and B. The 
probands of the families are indicated with an arrow and the healthy 
siblings of the patients are indicated with empty symbols. b The 
structural domains of NHLRC2 and location of the variants. c Neither 
full-length NHLRC2 (NHLRC2-FL) nor the isolated thioredoxin-like 
domain (NHLRC2-trx) produced in E. coli showed significant thiore-
doxin activity in the insulin-reduction assay. d Conservation of the 
thioredoxin-like domain region containing p.Asp148Tyr (p.D148Y) 
in red [5]. e QPCR showed a highly significant decrease in the rela-
tive quantity of NHLRC2 mRNA in patient-derived fibroblasts com-
pared to controls according to a two-tailed Student’s t-test. f Immu-
noblotting indicated a significant loss of the p.Asp148Tyr NHLRC2 
protein in fibroblasts from Patients 1–3 compared to the levels of 
GAPDH. g Immunoblotting data presented as numerical values 
measured using Image J and statistical analysis by a two-tailed Stu-
dent’s t-test. Abbreviations: Trx, thioredoxin; C, control; P, patient; 
FL, full length. Differences were considered as statistically signifi-
cant (*), with p value 0.01–0.05 and highly significant (***) with p 
value < 0.001
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contrast to the postnatal onset of the symptoms in humans, 
the timing of the effects of the zebrafish knockdown sug-
gests the morphant zebrafish model does not fully reflect the 
features of the human disease. We are currently working on 
generating a knockout zebrafish model to better observe the 
potential symptoms at later stages of development.
Autopsy studies revealed that in FINCA patients, there 
was increased angiomatosis-like leptomeningeal, cortical 
and superficial white matter vascularisation and conges-
tion, in addition to white matter degeneration and variable 
neuronal degeneration. According to currently available 
RNA expression data in Human Brain Transcriptome 
(http://hbatl as.org/), the average expression level of 
human NHLRC2 is similar among different regions of the 
human brain. The expression of mouse Nhlrc2 is the high-
est in astrocytes, oligodendrocyte progenitor cells, newly 
formed oligodendrocytes and in the endothelial cells [32]. 
Altogether, this expression data indicate that NHLRC2 is 
widely expressed in the different regions and cell types of 
the brain. However, based on the current knowledge on 
the function of NHLRC2 it is difficult to conclude the pri-
mary mechanism behind FINCA disease and to exclude the 
role of secondary processes such as ischemia as a cause 
of certain neuropathological findings described in our 
patients such as depletion of Purkinje cells and pyrami-
dal neurons in Ammon’s horn. Lung biopsy and autopsy 
studies showed severe interstitial fibrosis and previously 
undescribed granuloma-like lesions, which were enriched 
Table 2  Genotyping summary of Nhlrc2 knockout mouse offspring 
obtained through heterozygous breeding
χ2 test showed significant deviation from Mendelian segregation 
(p < 0.001)
P14 2  weeks, E10.5 embryonic day 10.5, E2.5 embryonic day 2.5, 
WT wild-type, Het heterozygous, Hom homozygous
Genotyping WT (%) Het (%) Hom (%) Total
P14 mice 32.0 68.0 0.0 154
E10.5 embryos 24.8 75.2 0.0 53
E2.5 embryos 31.1 68.9 0.0 45
Fig. 5  LacZ mouse tissue staining. Heterozygote  Nhlrc2tm1a mice had 
a strong β-galactosidase signal throughout the body. Heart and thy-
mus (a); lungs (b); kidneys, adrenal glands and gonads (c); liver (d) 
and brain (e, f) (e WT; f heterozygote  Nhlrc2tm1a mice). WT litter-
mates were negative for β-galactosidase signal
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Fig. 6  Transmission electron microscopy from the midbrain region 
of the 2-dpf-zebrafish morphant. a A cross section of a zebrafish 
embryo at 2 dpf with a circled area specifying the exact location from 
which the electron micrographs were taken. b Cells with excess vac-
uolisation or disintegration were classified as affected (marked with 
an asterisk in Fig.  6d). In the midbrain 5.8% of the 810 cells ana-
lysed were affected by the nhlrc2 splice site-blocking morpholinos, 
whereas only 1% of the 850 cells were affected in MO controls. 
c Midbrain of the random sequence morpholino injected control. d 
Midbrain of the nhlrc2 splice site-blocking morphant. Abbreviations: 
C cerebellum, M mesencephalon, T telencephalon, SB splice site-
blocking, MO morpholino. Differences were considered as statisti-
cally very significant (**) with p value 0.001–0.01
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with myofibroblasts that accumulate in areas surrounding 
granulomas in several granulomatous lung diseases such 
as sarcoidosis, atypical mycobacteriosis and tuberculosis 
[8]. The predominance of type II alveolar cells and pau-
city of type I cells were evident. Lung autopsy specimens 
additionally revealed DAD. Furthermore, all the patients 
had hepatomegaly. Liver samples for TEM were available 
only from one patient (Patient 2) revealing steatosis and 
accumulation of collagen bundles.
From the previous literature, we have found only one 
other “FINCA-like” cerebropulmonary disease called 
brain–lung–thyroid syndrome (BLT syndrome, OMIM 
118700) or choreoathetosis and congenital hypothyroid-
ism with or without pulmonary dysfunction (CAHTP, MIM 
#610978) that begins with muscular hypotonia followed 
by choreoathetosis, dystonia, ataxia, and dysarthria. This 
is an autosomal dominant infantile-onset disorder caused 
by mutations in thyroid transcription factor 1 (NKX2-1/
TITF1; 14q13.3) [30, 27]. The phenotype is less severe 
than in FINCA and varies between and within families; 
some patients show neonatal respiratory distress syndrome 
(RDS), developmental delay, symptoms of possible hypotha-
lamic dysfunction or congenital cardiac septal defects [27]. 
Neuroimaging in some NKX2-1 related cases has shown 
structural brain abnormalities including agenesis of the 
corpus callosum [19], and autopsies have revealed reduced 
numbers of striatal and neocortical interneurons consist-
ent with a defect in neuronal migration [12]. In addition 
to RDS in neonates, pulmonary disease may present with 
interstitial lung disease in young children, and pulmonary 
fibrosis in older persons [19]. Histologic studies on patients 
with NKX2-1 related pulmonary dysfunction have identi-
fied interstitial widening and pneumocyte hyperplasia, des-
quamative interstitial pneumonia, accumulation of foamy 
alveolar macrophages, and pulmonary alveolar proteinosis 
[6]. The risk for pulmonary carcinoma is increased in young 
adults with an NKX2-1 related disorder. In BLT syndrome, 
thyroid involvement may present as subclinical hypothyroid-
ism with mildly elevated thyroid stimulating hormone (TSH) 
or hyperthyrotropinemia. Additional symptoms, including 
failure to thrive, malabsorption, and intellectual deficit, have 
been reported in patients with deletions on chromosome 
14, including NKX2-1 (http://www.orpha .net). In FINCA 
disease, in addition to cerebropulmonary symptoms, we 
also observed failure to thrive, malabsorption, early-onset 
chronic haemolytic anaemia, and recurrent infections in 
all three patients. Furthermore, transient liver dysfunction 
(Patients 1 and 2), transient kidney dysfunction (Patient 
1), subclinical hypothyroidism (Patient 3, Electronic Sup-
plementary Material), a transient increase in serum tumour 
markers and a non-specific decrease in the oxidative activity 
of monocytes (Patient 2, Electronic Supplementary Mate-
rial) were noted.
Our studies indicate that NHLRC2 has a significant role 
in the CNS. However, further research is required to define 
the complex role of NHLRC2 in the pathogenesis of FINCA 
disease and, more commonly, its role in tissue fibrosis, neu-
rodegeneration and cerebral angiomatosis. The presentation 
of FINCA disease and potentially other diseases may vary 
in response to the genetic defect in NHLRC2, environmental 
factors and other genetic factors. Recently, NHLRC2 has 
been listed as one of six novel blood-based biomarkers for 
Alzheimer´s disease, indicating its yet undefined role in 
neurodegeneration [14]. Our expression analysis with LacZ-
reporter mice suggests widespread expression of Nhlrc2 
throughout the mouse embryo. This, in connection with the 
severe multi-organ phenotype of FINCA patients, indicates 
that NHLRC2 has a vital role in early embryogenesis and 
in maintenance of multi-organ homeostasis after birth. We 
propose that NHLRC2 variants should be considered in 
patients with phenotypes that present as a combination of 
neurological and respiratory symptoms or additional multi-
organ manifestations.
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